全球 qPCR 试剂市场规模（按最终用户、应用、包装类型、检测方法、地区、范围和预测）

qPCR 试剂市场规模及预测

2023 年 qPCR 试剂市场规模价值为 23.9135 亿美元，预计到 2031 年将达到 47.5095 亿美元，2024-2031 年预测期内的复合年增长率为 8.96%。

qPCR 试剂的全球市场驱动因子

qPCR 试剂市场的市场推动因素可能受到多种因素的影响。

技术开发：

提高 qPCR 检测的准确性、灵敏度和速度正在推动更好的 qPCR 技术的开发，包括更好的试剂、设备和软体。

扩大研究用途：

随着 qPCR 在转录组学、药物发现、基因组学和分子诊断等许多研究领域的应用不断扩大，市场也不断扩大。病毒量定量、生物标记分析、突变检测和基因表现分析都是 qPCR 的常见应用。

对个人化医疗的兴趣日益浓厚

qPCR 技术在分子诊断和个人化医疗领域变得越来越重要，因为它可用于识别基因突变、疾病标记和预测治疗结果。这促使对 qPCR 试剂的需求增加。

增加传染病检测：

COVID-19 疫情凸显了 qPCR 等快速且准确的传染病诊断方法的重要性。因此，对用于追踪和病毒鑑定的 qPCR 试剂的需求日益增加。

製药和生物技术市场成长：

随着生物技术和製药行业的增长以及研发活动投入的增加，药物发现、开发和验证程序中对 qPCR 试剂的需求正在增长。

自动化与高通量系统：

随着自动化 qPCR 系统和高通量平台在实验室和研究中心变得越来越普遍，对 qPCR 试剂的需求也日益增加。

政府措施与资金：

政府对分子生物学、遗传学和诊断学研究计画的支持计画、补助金和贷款透过鼓励使用 qPCR 技术和试剂促进了市场的成长。

由于癌症、心血管疾病和传染病等慢性疾病的发生率不断增加，临床诊断对 qPCR 试剂的需求日益增加。这些疾病需要 qPCR 等灵敏、准确的诊断技术。

限制全球 qPCR 试剂市场的因素

有几个因素可能会对 qPCR 试剂市场造成限制和课题。

成本高：

qPCR 试剂（包括酵素、引子、探针和其他成分）的成本相对较高，这可能会限制它们在某些研究或诊断环境中的采用。

复杂性与专业性：

qPCR 技术需要专门的设备和技术专长才能准确执行。对于没有必要资源的小型实验室或研究人员来说，这可能是一个障碍。

与替代技术的衝突：

其他分子生物学技术，例如数位 PCR（dPCR）和下一代定序（NGS），为核酸定量提供了替代方法，并与 qPCR 试剂竞争。

敏感度有限：

儘管 qPCR 灵敏度高，但它可能无法像数位 PCR 等新技术那样有效地检测低水平基因表现变化或罕见突变。

样本完整性和品质控制：

在整个 qPCR 过程中维持样本完整性和确保品质控制可能具有课题性，从而促使潜在的变异性和可靠性问题。

监理课题：

遵守监管要求，尤其是在诊断应用中，可能会给 qPCR 试剂製造商和用户带来课题，从而影响市场成长。

供应链中断：

供应链中断（例如原料短缺或製造课题）可能会影响 qPCR 试剂的可用性和定价。

多重化能力限制：

儘管可以进行多重 qPCR 检测，但可同时检测的目标数量受到限制，这可能会影响 qPCR 应用的可扩展性。

目录

第 1 章 全球 QPCR 试剂市场简介

市场概况
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第4章 全球 qPCR 试剂市场展望

• 概述
• 市场动态
  • 驱动程式
  • 阻碍因素
  • 机会
• 波特五力模型
• 价值链分析

第 5 章 全球 QPCR 试剂市场（依最终用户划分）

• 概述
• 製药和生技公司
• 法医科学实验室
• 研究实验室和学术机构
• 医院和诊断中心
• 临床研究机构

第6章 全球 qPCR 试剂市场（依应用）

• 概述
• 诊断应用
• 法医应用
• 研究用途

第 7 章 全球 qPCR 试剂市场（依包装类型）

• 概述
• qPCR 核心试剂盒 qPCR 预混液

第8章全球 qPCR 试剂市场（依检测方法）

• 概述 基于染料的 qPCR 试剂
• 基于探针和引子的 qPCR 试剂

第 9 章 全球 QPCR 试剂市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
  亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第 10 章全球 qPCR 试剂市场竞争格局

• 概述
• 各公司的市场排名
• 主要发展策略

第 11 章 公司简介

• Qiagen N.V
• Bio-Rad Laboratories
• Agilent Technologies
• Takara Bio. Inc
• Thermo Fischer Scientific Inc.
• Affymetrix Inc.
• Promega Corporation
• Quanta Biosciences
• F.Hoffman-La-Roche-Ltd

第 12 章 重大进展

• 产品发布/开发
• 合併和收购
• 业务扩展
• 伙伴关係和合作关係

第 13 章附录

• 相关研究

qPCR Reagents Market Size And Forecast

qPCR Reagents Market size was valued at USD 2391.35 Million in 2023 and is projected to reach USD 4750.95 Million by 2031, growing at a CAGR of 8.96% during the forecast period 2024-2031. Global qPCR Reagents Market Drivers The market drivers for the qPCR Reagents Market can be influenced by various factors. These may include: Technological Developments:

By increasing the precision, sensitivity, and speed of qPCR tests, ongoing developments in qPCR technology, such as better reagents, devices, and software, fuel market expansion.

Growing Use in Research:

The market is growing as a result of the growing use of qPCR in a number of research fields, including transcriptomics, drug discovery, genomics, and molecular diagnostics. Viral load quantification, biomarker analysis, mutation detection, and gene expression analysis are all common uses for qPCR.

Growing Interest in Personalised Medicine:

As qPCR technology is used to identify genetic variations, disease markers, and treatment response prediction, it is becoming more and more important in the field of molecular diagnostics and personalised medicine. This has led to an increase in the demand for qPCR reagents.

Increase in Testing for Infectious Diseases:

The COVID-19 pandemic brought to light the significance of quick and precise diagnostic methods, such as qPCR, for infectious diseases. As a result, there is now a greater need for qPCR reagents for tracking and virus identification.

Growing Markets for Pharmaceuticals and Biotechnology:

The need for qPCR reagents for drug discovery, development, and validation procedures is driven by the growth of the biotechnology and pharmaceutical sectors as well as higher investment in research and development activities.

Automation and High-Throughput Systems:

As automated qPCR systems and high-throughput platforms become more common in labs and research centres, there is a greater need for qPCR reagents since these systems need specific reagents to function well.

Government Initiatives and financing:

By promoting the use of qPCR technology and reagents, supportive government initiatives, grants, and financing for research projects in molecular biology, genetics, and diagnostics contribute to market growth.

The need for qPCR reagents in clinical diagnostics is being driven by the increasing frequency of chronic diseases, which include cancer, cardiovascular disorders, and infectious diseases. These diseases require sensitive and accurate diagnostic techniques, like qPCR.

Global qPCR Reagents Market Restraints

Several factors can act as restraints or challenges for the qPCR Reagents Market. These may include:

High Cost:

The cost of qPCR reagents, including enzymes, primers, probes, and other components, can be relatively high, which may limit their adoption in certain research or diagnostic settings.

Complexity and Technical Expertise:

qPCR techniques require specialized equipment and technical expertise to perform accurately. This can be a barrier for small laboratories or researchers without the necessary resources.

Competition from Alternative Technologies:

Other molecular biology techniques like digital PCR (dPCR) and next-generation sequencing (NGS) offer alternative methods for nucleic acid quantification, posing competition to qPCR reagents.

Limited Sensitivity:

While qPCR is highly sensitive, it may not detect low-level gene expression changes or rare mutations as effectively as newer technologies like digital PCR.

Sample Integrity and Quality Control:

Maintaining sample integrity and ensuring quality control throughout the qPCR process can be challenging, leading to potential variability and reliability issues.

Regulatory Challenges:

Compliance with regulatory requirements, especially in diagnostic applications, can pose challenges for qPCR reagent manufacturers and users, impacting market growth.

Supply Chain Disruptions:

Disruptions in the supply chain, such as shortages of raw materials or manufacturing challenges, can affect the availability and pricing of qPCR reagents.

Limited Multiplexing Capacity:

Although multiplex qPCR assays are possible, they may have limitations in terms of the number of targets that can be simultaneously detected, affecting the scalability of qPCR applications.

Global qPCR Reagents Market: Segmentation Analysis

The Global qPCR Reagents Market is Segmented on the basis of End-User, Application, Packaging Type, Detection Method, and Geography.

qPCR Reagents Market, By End-User

• Pharmaceutical and Biotechnology Companies
• Forensic Laboratories
• Research Laboratories and Academic Institutes
• Hospitals and Diagnostic Centres
• Clinical Research Organization

Based on End-User, The market is segmented into Pharmaceutical and Biotechnology Companies, Forensic Laboratories, Research Laboratories and Academic Institutes, Hospitals and Diagnostic Centres, and Clinical Research organizations. The Hospitals and Diagnostic have the largest growth of the Global qPCR Reagents Market due to the dominant market position of hospitals and diagnostic centers can be credited to the advancement of the healthcare system for effective diagnosis and treatment, the rising proportion of qPCR reagents initiated for diagnostic applications, and the benefits provided by qPCR in the diagnosis of diseases.

qPCR Reagents Market, By Application

• Diagnostic Application
• Forensic Application
• Research Application

Based on Application, The market is segmented into Diagnostic Application, Forensic Application, and Research Application. The research application has the highest growth of the Global qPCR Reagents Market because of their increasing applications in fields including stem cell research, microbiology, and agricultural production as compared to other segments of the market during the forecasted period.

qPCR Reagents Market, By Packaging Type

• qPCR Core Kits
• qPCR Master Mixes

Based on Packaging Type, The market is segmented into qPCR Core Kits and qPCR Master Mixes. The qPCR Core Kits has the largest growth of the Global qPCR Reagents Market due to its large market share is driven by factors such as low core kit prices, end-user flexibility, rising private-public funding for life science research, and growing market provision of qPCR core kits in countries involved throughout the projected period.

qPCR Reagents Market, By Detection Method

• Dye-Based qPCR Reagents
• Probes and Primer-Based qPCR Reagents

Based on Detection Method, The market is segmented into Dye-Based qPCR Reagents and Probes and Primer-Based qPCR Reagents. The Dye-Based qPCR Reagent has the largest growth of the Global qPCR Reagents Market. Dye-based diagnostic qualitative PCR is being used rapidly to identify nucleic acids that are important in the diagnosis of infectious diseases, cancer, and genetic problems, among many other things. Furthermore, Cancer Research UK predicts that the number of cancer patients is expected to rise significantly.

qPCR Reagents Market, By Geography

• North America
• Europ
• Asia Pacific
• Rest of the world
• On the basis of Geography, The market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Asia-Pacific is projected to be the highest growing market over the forecasted period due to the high penetration of global life sciences companies in this region, increasing government focus on raising awareness about gene-based diagnostics and therapeutics, rising public and private incentives for the implementation of novel qPCR technology solutions, and progress of cancer research in Japan.

Key Players

• The major players in the qPCR Reagents Market are:
• Thermo Fischer Scientific Inc.
• Agilent Technologies
• Affymetrix Inc.
• Takara Bio. Inc
• Qiagen N.V
• Bio-Rad Laboratories
• Promega Corporation

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL QPCR REAGENTS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL QPCR REAGENTS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL QPCR REAGENTS MARKET, BY END-USER

• 5.1 Overview
• 5.2 Pharmaceutical and Biotechnology Companies
• 5.3 Forensic Laboratories
• 5.4 Research Laboratories and Academic Institutes
• 5.5 Hospitals and Diagnostic Centres
• 5.6 Clinical Research Organization

6 GLOBAL QPCR REAGENTS MARKET, BY APPLICATIONS

• 6.1 Overview
• 6.2 Diagnostic Application
• 6.3 Forensic Application
• 6.4 Research Application

7 GLOBAL QPCR REAGENTS MARKET, BY PACKAGING TYPE

• 7.1 Overview
• 7.2 qPCR Core Kits
• 7.3 qPCR Master Mixes

8 GLOBAL QPCR REAGENTS MARKET, BY DETECTION METHOD

• 8.1 Overview
• 8.2 Dye-Based qPCR Reagents
• 8.3 Probes and Primer-Based qPCR Reagents

9 GLOBAL QPCR REAGENTS MARKET, BY GEOGRAPHY

• 9.1 Overview
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.3 Canada
  • 9.2.4 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 U.K.
  • 9.3.3 France
  • 9.3.4 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Rest of Asia Pacific
• 9.5 Rest of the World
  • 9.5.1 Latin America
  • 9.5.2 Middle East and Africa

10 GLOBAL QPCR REAGENTS MARKET COMPETITIVE LANDSCAPE

• 10.1 Overview
• 10.2 Company Market Ranking
• 10.3 Key Development Strategies

11 COMPANY PROFILES

• 11.1 Qiagen N.V
  • 11.1.1 Overview
  • 11.1.2 Financial Performance
  • 11.1.3 Product Outlook
  • 11.1.4 Key Developments
• 11.2 Bio-Rad Laboratories
  • 11.2.1 Overview
  • 11.2.2 Financial Performance
  • 11.2.3 Product Outlook
  • 11.2.4 Key Developments
• 11.3 Agilent Technologies
  • 11.3.1 Overview
  • 11.3.2 Financial Performance
  • 11.3.3 Product Outlook
  • 11.3.4 Key Developments
• 11.4 Takara Bio. Inc
  • 11.4.1 Overview
  • 11.4.2 Financial Performance
  • 11.4.3 Product Outlook
  • 11.4.4 Key Developments
• 11.5 Thermo Fischer Scientific Inc.
  • 11.5.1 Overview
  • 11.5.2 Financial Performance
  • 11.5.3 Product Outlook
  • 11.5.4 Key Developments
• 11.6 Affymetrix Inc.
  • 11.6.1 Overview
  • 11.6.2 Financial Performance
  • 11.6.3 Product Outlook
  • 11.6.4 Key Developments
• 11.7 Promega Corporation
  • 11.7.1 Overview
  • 11.7.2 Financial Performance
  • 11.7.3 Product Outlook
  • 11.7.4 Key Developments
• 11.8 Quanta Biosciences
  • 11.8.1 Overview
  • 11.8.2 Financial Performance
  • 11.8.3 Product Outlook
  • 11.8.4 Key Developments
• 11.9 F.Hoffman-La-Roche-Ltd
  • 11.9.1 Overview
  • 11.9.2 Financial Performance
  • 11.9.3 Product Outlook
  • 11.9.4 Key Developments

12 KEY DEVELOPMENTS

• 12.1 Product Launches/Developments
• 12.2 Mergers and Acquisitions
• 12.3 Business Expansions
• 12.4 Partnerships and Collaborations

13 Appendix

• 13.1 Related Research